Rhinostop nasal drops 0.1% 10ml
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Xylometazoline
Release form
Drops
Composition
1 ml of drops contains: Active substance: Xylometazoline (as hydrochloride) 0.001 g; Excipients: benzalkonium chloride; ethylenediaminetetraacetic acid disodium salt (Trilon B); potassium phosphate monosubstituted; sodium phosphate disubstituted; sodium chloride; purified water
Pharmacological effect
Rhinostop is a vasoconstrictor for local use in ENT practice. Alpha adrenomimetic. When applied to the mucous membranes causes vasoconstriction, as a result, local hyperemia and edema are reduced. When rhinitis facilitates nasal breathing.
Pharmacokinetics
When applied topically, it is practically not absorbed, plasma concentrations are so small that they cannot be determined by modern analytical methods.
Indications
Acute allergic rhinitis, sinusitis, pollinosis, otitis media (to reduce swelling of the nasopharyngeal mucosa), preparing the patient for diagnostic procedures in the nasal passages.
Contraindications
Angle-closure glaucoma, atrophic rhinitis, arterial hypertension, tachycardia, marked atherosclerosis, hyperthyroidism, surgery on the meninges (in history), increased sensitivity to xylometazoline.
Use during pregnancy and lactation
During pregnancy and lactation, Rhinostop should be used only after a thorough assessment of the risk-benefit ratio for the mother and the fetus; the recommended doses should not be exceeded.
Dosage and administration
Intranasal, in each nasal passage, for adults and children over 6 years old - 1–2 drops (0.1% solution) 2–3 times a day, for children from 2 to 6 years - 1-2 drops (0.05%) solution) 1-2 times a day. Apply no more than 3 times a day for 3-5 days (with longer use, a break for 3-5 days is required).
Side effects
With frequent and / or long-term use: irritation of the mucous membranes, burning, stinging, sneezing, dry nasal mucosa, hypersecretion. sleep disorders, visual disturbances. With prolonged use in high doses: depressive state.